Objective: Recent genome-wide association studies (GWAS) have identified multiple novel loci associated with adiposity in European-derived study populations. Limited study of these loci has been reported in African Americans. Here we examined the effects of these previously identified adiposity loci in African Americans. Methods: A total of 46 representative single-nucleotide polymorphisms (SNPs) in 19 loci that were previously reported in GWAS in Europeans (including FTO and MC4R) were genotyped in 4992 subjects from six African-American cohorts. These SNPs were tested for association with body mass index (BMI) after adjustment for age, gender, disease status and population structure in each cohort. Meta-analysis was conducted to combine the results. Results: Meta-analysis of 4992 subjects revealed seven SNPs near four loci, including NEGR1, TMEM18, SH2B1/ATP2A1 and MC4R, showing significant association at 0.005oPo0.05, and had effect sizes between 0.04 and 0.06 s.d. units (or 0.30 to 0.44 kg m À2 ) of BMI for each copy of the BMI-increasing allele. The most significantly associated SNPs (rs9424977, rs3101336 and rs2568958) are located in the NEGR1 gene (P ¼ 0.005, 0.020 and 0.019, respectively). Conclusion: We replicated the association of variants at four loci in six African-American cohorts that demonstrated a consistent direction of association with previous studies of adiposity in Europeans. These loci are all highly expressed in the brain, consistent with an important role for central nervous system processes in weight regulation. However, further comprehensive examination of these regions may be necessary to fine map and elucidate for possible genetic differences between these two populations.
Introduction
Obesity is a major public health problem leading to increased mortality and comorbidities, such as type 2 diabetes (T2DM), metabolic syndrome, coronary heart disease, stroke, cancers, liver and gallbladder disease, sleep disorders and osteoarthritis. 1 The World Health Organization , respectively. The prevalence of obesity in both adults and adolescents has been increasing in the past decades in the United States. In fact, obesity incidence has doubled in adults aged 20 years or older from 1980 to 2002. 2, 3 Marked racial and gender differences in the prevalence of obesity have been observed. In the National Health and Nutrition Examination Survey conducted in 2003-2004, 31% of European American adults were obese and 4% were morbidly obese. The corresponding figures in African Americans were even more alarming (45% and 11%, respectively), with higher prevalence of obesity in black women (54%) than in black men (34%). 4 The increasing prevalence of obesity is contributed by the excessive caloric intake and diminished physical activity in the modern environment. However, genetic factors modulate the impact of the affluent environment on each individual. Considerable evidence from familial segregation and twin studies suggest that there is a significant genetic contribution to adiposity. 5 Heritability estimates for BMI have been reported between 60-90% in African Americans. [6] [7] [8] Recently, large-scale genome-wide association studies (GWAS) and meta-analyses in Europeans have revealed over 40 novel adiposity loci associated with BMI, waist circumference and/or waist-hip ratio. The strongest adiposity locus identified to date is FTO. [9] [10] [11] [12] Additional loci were subsequently identified to be located at, or near the genes BCDIN3D/FAIM2, CDH12, CHST8/KCTD15, CTNNBL1, GNPDA2, LGR4/LIN7C/BDNF, LYPlAL1, MAF, MC4R, MSRA, MTCH2, NEGR1, NPC1, NRXN3, PARD3B, PCSK1, PRL, PTER, SEC16B/RASAL2, SFRS10/ETV5/DGKG, SH2B1/ATP2A1, TFAP2B and TMEM18. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] Several of these loci have been confirmed in Asian populations by GWAS and replication studies. [23] [24] [25] [26] Replication studies in African Americans have revealed inconsistent evidence of association of MC4R 27, 28 and FTO [29] [30] [31] [32] with adiposity measures, and limited data is available for other loci. In the present study, we examined the influence of single-nucleotide polymorphisms (SNPs) at the loci recently identified in GWAS on adiposity in multiple African-American populations. [13] [14] [15] [16] [17] [18] [19] [20] Subjects and methods
Subjects
Six African-American cohorts were used in the present study. Cohorts 1 and 2 were derived from a type 2 diabetic nephropathy GWAS. The community non-diabetic cohort (cohort 1) consisted of 816 subjects who reported no history of diabetes and who were recruited from the community and internal medicine clinics at Wake Forest University School of Medicine. Cohort 2 consisted of 899 subjects with T2DM and end-stage renal disease (T2DM-ESRD), recruited from dialysis facilities in the southeastern US. 33 An additional community non-diabetic cohort (cohort 3), including 621 subjects (616 unrelated subjects and 5 related subjects from two nuclear families) who reported no history of diabetes, was recruited from the community and internal medicine clinics similar to that of cohort 1. A second diabetic cohort (cohort 4) consisting of 891 subjects with T2DM and 617 subjects with T2DM-ESRD (1005 unrelated subjects and 503 related subjects from 178 nuclear families) was recruited from the community, churches, health fairs, medical clinics and dialysis facilities. The Diabetes Heart Studies cohort (cohort 5) consisted of subjects recruited from the community and internal medicine clinics in two studies that examined the sub-clinical cardiovascular risk in T2DM. A subset of 211 unrelated subjects from the African American Diabetes Heart Study 34 and 81 subjects from the family- 
Clinical studies
Height and weight was measured in all study subjects. BMI is calculated as weight divided by square of height. BMIX30 kg m À2 is considered obese. Genomic DNA was extracted from blood samples using the PureGene system (Gentra Systems, Minneapolis, MN, USA).
Genotyping and quality control A total of 46 SNPs at 19 novel adiposity loci, identified through recent GWAS in Europeans, were selected for replication in our African-American cohorts. Selection criteria included key SNPs that reached genome-wide significance (Po5 Â 10
À8
) and nearby reported SNPs showing nominal association in these previous studies. 10, [13] [14] [15] [16] [17] [18] [19] [20] A total of three outlier observations were removed from further analyses. The data were then adjusted for age in a linear model and residuals were standardized to a mean of zero and variance of one (that is, Z-score). These Z-scores are the primary unit of analysis for both within individual cohorts and the meta-analyses.
Association. For cohorts 1 and 2, the associations of BMI Z-scores with SNPs were tested by linear regression under an additive model using the program QSNPGWA (www. phs.wfubmc.edu), with additional covariate adjustment for PC1. For cohorts 3-6, a variance component measured genotype method implemented in SOLAR (Almasy and Blangero 1998, http://txbiomed.org/departments/genetics/) was used for association tests in order to account for familial relationships within each cohort. Associations of BMI Z-scores with SNPs were tested under an additive model with adjustment for proportion of African ancestry. Familial correlation was accounted for using a kinship coefficient matrix, in which a correlation was calculated for each set of related pairs.
Meta-analysis.
Association results from all six cohorts were combined using the inverse variance weighted method implemented in METAL (http://www.sph.umich.edu/csg/ abecasis/metal/). In order to account for modest relatedness between the cohorts 1-4, BMI Z-scores of all six cohorts were pooled and analyzed together, using variance component method for comparison with the meta-analysis method. To evaluate the potential confounding effect of disease, 2111 community non-diabetic subjects from cohorts 1, 3 and 6, 1516 T2DM-ESRD subjects from cohorts 2 and 4, and 1362 T2DM subjects from cohorts 4, 5 and 6, were separately analyzed using linear regression and variance component methods, as appropriate. The association results were then European-derived adiposity loci in African Americans JM Hester et al combined using METAL to assess the overall SNP association in non-diabetics, T2DM-ESRD and T2DM separately. For loci showing multiple associations, conditional SNP analyses that include multiple SNPs as independent variables were performed, using variance component method in the pooled samples to evaluate the independence of the association signals.
All statistical tests were performed by QSNPGWA, PLINK (http://pngu.mgh.harvard.edu/~purcell/plink/) or SAS v.9.1 (SAS Institute, Cary, NC, USA) unless specified otherwise. Posterior study power was calculated using genetic power calculator. 40 A nominal P-value o0.05 in the meta-analysis was considered as evidence of significance. To correct for multiple testing, a P-value o0.0011 (0.05/46 SNPs) was considered significant after Bonferroni correction.
Results

Clinical characteristics of the study samples
The clinical characteristics of the study samples in all six cohorts are shown in Table 1 . Due to the nature of sample collection, the cohorts consisted of community non-diabetic (cohorts 1 and 3), community-based (cohort 6) or diabetic subjects (cohorts 2, 4 and 5). The distributions of BMI are comparable among all cohorts, except for higher mean BMI (35.3 kg m
À2
) and higher prevalence of obesity (74.3%) in the Diabetes Heart Studies (cohort 5). In view of the heterogeneous phenotypes among the study cohorts, BMI Z-scores were calculated in sex-and disease-specific strata and then combined in each cohort separately for association analyses.
We either genotyped or imputed (for 24 SNPs in cohorts 1 and 2 only) 46 representative SNPs in 19 adiposity loci reported in recent GWAS in six African-American cohorts. Table 2 summarizes the individual cohort and meta-analysis results of these SNPs for association with BMI, using an inverse variance method. From the results of the metaanalysis, seven SNPs showed significant association at 0.005oPo0.05 with effect sizes between 0.04 and 0.06 s.d. units (or 0.30 to 0.44 kg m À2 ) of BMI for each copy of effect allele. These seven SNPs were located at, or near four different loci including, NEGR1, TMEM18, SH2B1/ATP2A1 and MC4R. The most significantly associated SNPs (rs9424977, rs3101336 and rs2568958) are located on chromosome 1 near NEGR1 (0.005oPo0.02). The T-allele of rs9424977 showed a trend of association with increased BMI in four of the six cohorts. The rs3101336 and rs2568958 are highly correlated with each other (r 2 ¼ 0.99), but moderately correlated with rs9424977 (r 2 ¼ 0.55) in our samples. Conditional analysis including both rs9424977 and rs3101336 removed the significant associations (P ¼ 0.175 for rs9424977 and 0.676 for rs3101336) and suggested that they represent the same association signal. Two SNPs located near the MC4R gene were associated with BMI in the meta-analysis (P ¼ 0.018 for rs477181; P ¼ 0.046 for rs4450508). The G-alleles of both rs477181 and rs4450508 showed a consistent trend of increased BMI across most of the cohorts. These two SNPs reside in the same LD block (D 0 ¼ 0.97), but are not highly correlated (r 2 ¼ 0.35) in our samples. Conditional analysis including rs477181 and rs4450508 removed the significant associations (P ¼ 0.152 for rs477181 and 0.420 for rs4450508), again suggesting that they represent the same association signal.
There was no evidence of heterogeneity of the effect sizes of all seven significantly associated SNPs across the six cohorts (P heterogeneity 40.05). None of these SNPs showed significant association (all P40.0011) after Bonferroni correction for multiple testing. We further investigated the association of these 46 SNPs in 2111 community non-diabetic, 1516 T2DM-ESRD and 1362 T2DM subjects from cohorts 1 to 6 (Supplementary Table 2 ). The effect sizes ranged from 0.0005 to 0.24, 0.003 to 0.11, and 0.002 to 0.16 s.d. units, respectively, for the three groups. Overall, there was no significant heterogeneity of effect sizes among the non-diabetic, T2DM-ESRD and T2DM groups (P heterogeneity 40.05), except for rs10508503 in PTER. The non-significant results for most SNPs in this subset analysis are likely to be attributed to reduced sample size and study power. Due to modest relatedness between the cohorts, the association analyses of the 46 SNPs were repeated, using variance component method to combine all samples into one single group (Supplementary Table 3 ). The P-value results are highly correlated with the meta-analysis method (slope ¼ 0.965, intercept ¼ 0.024 by linear regression model).
Discussion
We examined 46 SNPs in 19 loci identified in recent GWAS in European-derived populations for association with obesity in six African-American cohorts. Meta-analysis revealed seven SNPs (rs94224977, rs3101336, rs2568958, rs2867125, rs7498665, rs477181 and rs4450508) located at, or near the four loci (NEGR1, TMEM18, SH2B1 and MC4R), showing suggestive association with BMI (0.005oPo0.05) ( Table 2) . Although none of the SNPs showed significant association across all six cohorts due to modest sample size, the consistent direction of association with the European data may indicate their role in the modulation of BMI levels in African Americans.
The NEGR1 gene is located on chromosome 1p31 and is involved in the regulation of neurite outgrowth in the developing brain. 41, 42 In the NEGR1 region, the three most significantly associated SNPs from our study (rs9424977, European-derived adiposity loci in African Americans JM Hester et al LGR4, LIN7C, BDNF LGR4, LIN7C, BDNF LGR4, LIN7C, BDNF LGR4, LIN7C, BDNF Indicates SNPs with significant heterogeneity in P-values across the six studies (P heterogeneity o0.05).
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The direction of association is the same between the two populations (Supplementary Table 4 ). The TMEM18 gene located at chromosome 2p25, has recently been identified as a modulator of glioma-directed stem cell migration and may be involved in cell movement in general. 43 The encoded protein is localized to the nucleus, widely expressed in fetal and adult tissues and well conserved among divergent species. TMEM18 contains one associated SNP from our study, rs2867125. The reported effect size in Europeans for rs2867125 is 0.061 s.d. unit of BMI, 17 which is comparable to the effect size of 0.06 s.d. unit
of BMI observed in our study, with same direction of the association. The SH2B1 gene located at 16p11.2 has previously been shown to associate with increased serum leptin, total fat and waist circumference, and is a strong prior candidate for regulating body weight. 44 Our study confirms rs7498665, a non-synonymous SNP (T484A), to be associated with BMI in African Americans, with higher effect size and same direction of association, as compared with the Europeans (b ¼ 0.06 versus 0.036 s.d. unit of BMI, respectively).
17
In humans, multiple rare mutations conferring loss of function in the MC4R gene are associated with hyperphagia, severe childhood obesity and hyperinsulinemia. 45 Experimental studies show that MC4R is a key regulator of energy balance, influencing food intake and energy expenditure through functionally divergent central melanocortin neuronal pathways. 46 MC4R contains two SNPs that were significantly associated with BMI in our study. The rs477181 and rs4450508 are located in the same LD block (D 0 ¼ 0.97) at chromosome 18q21, with effect sizes of 0.05 and 0.04 s.d. unit of BMI, respectively. Although the G-allele of rs477181 was associated with BMI in both the Europeans and our African-American samples, however, the direction of association for rs4450508 differs between the two populations (Supplementary Table 4 ).
Other studies have examined the influence of MC4R in African-derived populations. Grant et al. 27 evaluated the MC4R locus in a cohort of 4688 European American children and 3723 African-American children. The rs571312, rs10871777 and rs476828 (perfect surrogates for rs17782313, an SNP widely replicated in European populations) yielded odds ratios in the European American cohort of 1.137-1.145 (0.042oPo0.054) for obesity, but there was no significant association with these SNPs in the African-American cohort. However, they observed significant association with rs1942880 (P ¼ 0.008) and rs12457166 (P ¼ 0.013), which are located in the same LD region with rs633265 (r 2 ¼ 0.22,
018) reported in this study. The rs17782313 shows a trend towards the association with BMI in our study (P ¼ 0.08); however, there was significant heterogeneity in the effect sizes across the six cohorts (P heterogeneity ¼ 0.007). Additionally, the T-allele was associated with increased BMI in our study as opposed to the C-allele reported in the European populations, 14 though allele frequencies are similar between the two populations (Supplementary Table 4 Despite some success in recent replication efforts involving FTO, there is a lack of evidence for association with BMI in the African-American populations from our study. We genotyped 10 index SNPs located across the FTO region in all six cohorts. We were unable to replicate association at any of these loci, though the direction of association was consistent with previous studies in Europeans (Supplementary Table 4 ). These negative results may partly be due to a lack of study power. The reported effect size for the A-allele of rs8050136 in Europeans is 0.08 s.d. unit of BMI, 17 and given the respective allele frequency of 0.45 in our African-American samples, we would have 98 and 75% power to detect association at a-level of 0.05 and 0.0011, respectively, under an additive model. However, given our sample size, allele
European-derived adiposity loci in African Americans JM Hester et al frequency and the effect size in our study of 0.03 s.d. unit of BMI for rs8050136, we had only 32 and 3.6% power to detect association at a-level of 0.05 and 0.0011, respectively. On the other hand, our strongest association observed was for rs9424977 at NEGR1 (P ¼ 0.005 in the meta-analysis, Table 2 ). The effect size of this SNP in our samples is 0.06 s.d. unit of BMI, and given the BMI-increasing allele frequency of 0.46, we had an estimated 85 and 39% power to detect association at a-level of 0.05 and 0.0011, respectively. In general, we have good power (X80%) to detect an effect size of 0.06 s.d. unit of BMI with an allele frequency of at least 0.40 at a-level of 0.05. However, after correction for multiple testing, we would need more than 10 000 samples to have comparable power. Given the prior association of these SNPs in European studies, we primarily presented significance levels without multiple comparisons to enhance study power. Our findings may reflect both allelic and locus heterogeneity in African Americans as compared with the European-derived populations. Larger sample sizes and thorough examination of these loci will be required to determine their effects in African Americans. Although we were able to replicate moderate association with BMI at four loci in our study, some of the discrepant findings between our study and those performed in European populations could be due to several factors.
(1) The study power of our samples may be limited. There are a substantial number of associated SNPs that showed large differences in allele frequencies between the ancestral HapMap European (CEU) and African (YRI) populations (Supplementary Table 4 ). Some of the SNPs, such as those in PRL, PTER, PCSK1 and MC4R are, or nearly are monomorphic in the YRI population, which will have little, if any, power to be detected. In order to increase sample size and study power, we used both healthy subjects and subjects with T2DM or T2DM-ESRD. As obesity is a risk factor of diabetes, it is unclear if the presence of T2DM or ESRD will in turn influence the genetic effect on adiposity measures. Some of the earlier studies on adiposity have used patients with various metabolic diseases (for example, T2DM, coronary artery disease, hypertension) as part of the gene discovery cohorts to increase study power and did not show strong heterogeneity of effect size between the healthy subjects and the patients. 16, 17 In the present study, the effect sizes were comparable in non-diabetic, T2DM-ESRD and T2DM subjects in the meta-analysis, suggesting that the presence of disease has minimal effect on the genetic associations. Studies in other ethnicities, particularly African-derived populations, are potentially valuable as they may help to fine map the signals of association and, because additional variants present at high frequency in African-derived populations may be absent or rare in European samples. 48 Additionally, it is not clear whether associations found in the European samples can be consistently replicated in the samples of predominantly recent African ancestry; genetic, environmental or phenotypic heterogeneity, gene by environment interactions, or different recombination histories between populations could all contribute to a lack of replication in African-derived populations. Along with differences in the prevalence of obesity between AfricanAmerican and European-derived populations, there are also ethnic differences in metabolic risk factors. 49 African Americans have different distribution of fat, with lower amounts of visceral fat, compared with the non-Hispanic whites. 50 In summary, we replicated association of seven key SNPs at four loci (NEGR1, TMEM18, SH2B1 and MC4R) in six AfricanAmerican cohorts that demonstrated consistent association with previous studies of adiposity in Europeans. These loci are all highly expressed in the brain (and several especially in the hypothalamus), consistent with an important role for central nervous system processes in weight regulation. However, further comprehensive examination of these regions may be necessary to confirm our findings and elucidate for possible genetic differences in different populations.
